For research use only. PeptaBase is for informational and laboratory research reference only. No medical claims are made and nothing on this site is intended to diagnose, treat, cure or prevent any disease.
PeptaBase
500+ PubMed CitationsFree To UseNo Account Required
Back to Database
Longevity & Mitochondrial

NAD+ Protocol

Dosing & Research

Last Updated: September 4, 2026

Chemical Identity
Amino Acid Sequence
N/A - dinucleotide, not a peptide
Molecular Formula
C21H27N7O14P2
Molecular Weight
663.43 g/mol
CAS Number
53-84-9

Cellular energy metabolism, Sirtuin-related research, Mitochondrial function, Age-related metabolic decline

Evidence Level
Mixed Evidence
Species Studied
Human • Mouse • Rat
Half-Life
Route-dependent; not simply summarized by single plasma value
Administration
Subcutaneous
Frequency
2-3x weekly (titrated up)

How It Works

  • Cellular energy metabolism
  • Sirtuin-related research
  • Mitochondrial function
  • Age-related metabolic decline

Dosing Structure

Dose
50–100 mg per session
Frequency
2-3x weekly (titrated up)
Notes
SubQ titration: Week 1-2: 25mg 2x per week (may feel lethargic as body adjusts to increased NAD levels) | Week 3-4: 50mg 2x per week | Week 5-6: 50mg 3x per week | Week 7+: may continue to increase as needed until reaching a max of 100mg 3x per week. Inject: SubQ abdomen/thigh. Morning preferred. Break: 4-8 weeks between intensive cycles.

Example Protocols

Dose: 50–100 mg per session
Frequency: 2-3x weekly (titrated up)
Duration: Ongoing
Off Period: Not listed
Calculate dosing →

Find Research Grade NAD+

Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.

Vendor One Research Labs

COA Verified

Third-party COA-verified research peptides with published batch testing.

Source Coming Soon

Vendor Two Sciences

Purity Tested

US-based research compound supplier with independent purity testing.

Source Coming Soon

Vendor Three Peptide Co.

Bulk research peptide sourcing with batch-level documentation.

Source Coming Soon
View all recommended vendors →

Protocol Notes

SubQ titration
Week 1-2: 25mg 2x per week (may feel lethargic as body adjusts to increased NAD levels)Week 3-4: 50mg 2x per weekWeek 5-6: 50mg 3x per weekWeek 7+: may continue to increase as needed until reaching a max of 100mg 3x per week
Inject: SubQ abdomen/thigh.
Morning preferred.
Break: 4-8 weeks between intensive cycles.

What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell that acts as an electron carrier in energy production and as a substrate for enzymes like sirtuins and PARP that govern DNA repair and stress response. NAD+ levels decline approximately 50% between ages 40–60 in multiple tissues. Supplementation research explores whether restoring NAD+ levels can slow aging-related decline in metabolism, cognition, and cellular integrity.

Research Observations - Not Medical Claims
  • NR supplementation (Elysium Basis trial, 2018; PMID: 29184669): 250 mg and 500 mg NR daily raised whole-blood NAD+ by 40% and 90% respectively over 8 weeks in healthy older adults - first confirmed human evidence that oral NAD+ precursors raise systemic NAD+.
  • NMN in older adults (Yamaguchi et al., 2022; PMID: 34912960): 250 mg/day oral NMN for 12 weeks significantly increased blood NAD+ and improved muscle performance metrics in older men.
  • IV NAD+ (case series, Birkmayer): Intravenous NAD+ infusion (500–1000 mg) acutely raises blood NAD+ to supraphysiological levels; used clinically in addiction treatment research.
  • Sirtuin activation: In aged mice, NMN administration restored NAD+ to youthful levels, improved mitochondrial function, and increased physical endurance by ~80% vs. untreated aged controls (Gomes et al., 2013; PMID: 24231807).
  • Cognitive function: NMN supplementation in 12-month-old mice improved spatial learning and memory performance; proposed mechanism involves cerebrovascular NAD+ restoration.

Evidence Summary

Mixed EvidenceOral NR/NMN: Dietary supplements (not FDA approved as drug) - Research Only for injectable forms
Evidence StrengthModerate
PreliminaryModerateStrong
Curated Citations3
Largest Study (n)120
Most Recent Study2024
Species Studied
HumanMouseRat

Commonly Researched With

Epithalon
Both target cellular aging - NAD+ restores metabolic and mitochondrial function while Epithalon addresses telomere maintenance.
Tirzepatide
NAD+ restoration is studied in metabolic disease contexts alongside GLP-1 class drugs for potential additive insulin sensitivity and mitochondrial effects.
GHK-Cu
GHK-Cu's broad gene expression upregulation includes DNA repair pathways that overlap with NAD+-PARP signaling.

Research & Studies

Loading citations…

Research Feedback

0 approved

For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.

Related Peptides

Epithalon
Longevity & Mitochondrial
FOXO4-DRI
Longevity & Mitochondrial
Glutathione
Longevity & Mitochondrial
Humanin
Longevity & Mitochondrial